328 related articles for article (PubMed ID: 7751182)
1. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system.
Stuschke M; Budach V; Stüben G; Streffer C; Sack H
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):395-408. PubMed ID: 7751182
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitivity, repair capacity, and stem cell fraction in human soft tissue tumors: an in vitro study using multicellular spheroids and the colony assay.
Stuschke M; Budach V; Klaes W; Sack H
Int J Radiat Oncol Biol Phys; 1992; 23(1):69-80. PubMed ID: 1572832
[TBL] [Abstract][Full Text] [Related]
3. Radioresponsiveness of human glioma, sarcoma, and breast cancer spheroids depends on tumor differentiation.
Stuschke M; Budach V; Sack H
Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):627-36. PubMed ID: 8226158
[TBL] [Abstract][Full Text] [Related]
4. A rationale for fractionation for slowly proliferating tumors such as prostatic adenocarcinoma.
Fowler JF; Ritter MA
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):521-9. PubMed ID: 7751194
[TBL] [Abstract][Full Text] [Related]
5. Influence of cellular radiation sensitivity on local tumor control of human melanoma xenografts given fractionated radiation treatment.
Rofstad EK
Cancer Res; 1991 Sep; 51(17):4609-12. PubMed ID: 1873806
[TBL] [Abstract][Full Text] [Related]
6. Radioresponsiveness, sublethal damage repair and stem cell rate in spheroids from three human tumor lines: comparison with xenograft data.
Stuschke M; Budach V; Budach W; Feldmann HJ; Sack H
Int J Radiat Oncol Biol Phys; 1992; 24(1):119-26. PubMed ID: 1512147
[TBL] [Abstract][Full Text] [Related]
7. Substructure in the radiation survival response at low dose in cells of human tumor cell lines.
Skarsgard LD; Skwarchuk MW; Wouters BG; Durand RE
Radiat Res; 1996 Oct; 146(4):388-98. PubMed ID: 8927711
[TBL] [Abstract][Full Text] [Related]
8. Response of human tumor cells of varying radiosensitivity and radiocurability to fractionated irradiation.
Dahlberg WK; Azzam EI; Yu Y; Little JB
Cancer Res; 1999 Oct; 59(20):5365-9. PubMed ID: 10537321
[TBL] [Abstract][Full Text] [Related]
9. Comparison of high dose rate, low dose rate, and high dose rate fractionated radiation for optimizing differences in radiosensitivities in vitro.
Wilkins RC; Ng CE; Raaphorst GP
Radiat Oncol Investig; 1998; 6(5):209-15. PubMed ID: 9822167
[TBL] [Abstract][Full Text] [Related]
10. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell spheroids as a model for evaluation of metabolic changes after irradiation.
Senekowitsch-Schmidtke R; Matzen K; Truckenbrodt R; Mattes J; Heiss P; Schwaiger M
J Nucl Med; 1998 Oct; 39(10):1762-8. PubMed ID: 9776284
[TBL] [Abstract][Full Text] [Related]
12. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
[TBL] [Abstract][Full Text] [Related]
13. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy.
Paganetti H
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):892-900. PubMed ID: 16199319
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
15. Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.
Otsuka S; Shibamoto Y; Iwata H; Murata R; Sugie C; Ito M; Ogino H
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1538-43. PubMed ID: 22115556
[TBL] [Abstract][Full Text] [Related]
16. Protracted exposure radiosensitization of experimental human malignant glioma.
Williams JA; Williams JR; Yuan X; Dillehay LE
Radiat Oncol Investig; 1998; 6(6):255-63. PubMed ID: 9885941
[TBL] [Abstract][Full Text] [Related]
17. Multicellular tumor spheroids in radiotherapy research (review).
Schwachöfer JH
Anticancer Res; 1990; 10(4):963-9. PubMed ID: 2200335
[TBL] [Abstract][Full Text] [Related]
18. Fractionated irradiation of five human lung cancer cell lines and prediction of survival according to a radiobiology model.
Hedman M; Bergqvist M; Brattström D; Brodin O
Anticancer Res; 2011 Apr; 31(4):1125-30. PubMed ID: 21508355
[TBL] [Abstract][Full Text] [Related]
19. Clinical radiobiology of stage T2-T3 bladder cancer.
Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
[TBL] [Abstract][Full Text] [Related]
20. Moderately low alpha/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy.
Suwinski R; Wzietek I; Tarnawski R; Namysl-Kaletka A; Kryj M; Chmielarz A; Wydmanski J
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):793-9. PubMed ID: 17499451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
